Loading cancer entity…
Loading cancer entity…
Clinical trials
175 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00001452 | Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex | completed | — | 1,387 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Sep 22, 2026 | clinicaltrials |
| NCT05005715 | Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery | completed | Phase 2 | 64 | Seoul National University Hospital |
| 1 |
| Jul 23, 2026 |
| clinicaltrials |
| NCT04042753 | Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors | completed | Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT02750371 | Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory(ISOMAB) | completed | N/A | 17 | University Hospital, BordeauxOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07247526 | Effect of Foot Bath on Anxiety and Physiological Parameters | completed | N/A | 100 | Trakya UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT06826170 | Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)(HYPOADENO) | completed | N/A | 25 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT04074642 | OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.(FIRST) | completed | N/A | 21 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT05822817 | Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery | completed | Phase 4 | 252 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT04584866 | Semi-sitting Versus Supine Position in Endoscopic Skull Base Surgery(PosESS) | completed | N/A | 54 | University Hospital, Basel, SwitzerlandOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT03927183 | Extended Support for Persons With Pituitary Tumours After Surgery | completed | N/A | 86 | Göteborg UniversityOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06752824 | Analgesia Nociception Index (ANI) in Intracranial Surgical Anesthesia(ANI) | completed | — | 75 | Trakya UniversityOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT03677713 | Nasal Packing Following Endoscopic Endonasal Pituitary Resection | completed | N/A | 60 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT05448690 | Comparative Effectiveness of Different Surgical Approaches for Giant Pituitary Adenomas | completed | N/A | 600 | Huashan HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT01794793 | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | completed | Phase 4 | 337 | RECORDATI GROUPINDUSTRY | 28 | Oct 1, 2024 | clinicaltrials |
| NCT06526481 | Nasoseptal Double Flap Versus Rescue Flap in Endoscopic Transsphenoidal Pituitary Surgery | completed | N/A | 56 | Mansoura UniversityOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT03636568 | Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)(DHAPS) | completed | N/A | 300 | Washington University School of MedicineOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT01556230 | Prospective Study of Clinically Nonfunctioning Pituitary Adenomas(PAPS) | completed | — | 292 | Columbia UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT03038308 | Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole | completed | Phase 1 / Phase 2 | 16 | Columbia UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05236829 | Exercise Capacity and Physical Activity Level in Prolactinoma Patients | completed | — | 38 | Hacettepe UniversityOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT03284775 | Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma | completed | N/A | 5 | University College, LondonOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT06053437 | Prognostic Indicators in Pituitary Adenoma Surgery: a Comprehensive Analysis of Surgical Outcomes and Complications.(Hyp'Op) | completed | — | 211 | Central Hospital, Nancy, FranceOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT01689727 | Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors | completed | Phase 2 | 40 | EndocyteINDUSTRY | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05088252 | Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection | completed | N/A | 112 | Beijing Tiantan HospitalOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT04212793 | Detection of PitNET Tissue During TSS Using Bevacizumab-800CW(DEPARTURE) | completed | Phase 1 | 20 | University Medical Center GroningenOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT00565903 | Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome(PPB) | completed | — | 1,247 | Ashley HillOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT04782596 | Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions | completed | N/A | 30 | University Hospital OstravaOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT03624114 | Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery(Scope) | completed | — | 40 | University Hospital, Basel, SwitzerlandOTHER | 2 | Aug 3, 2022 | clinicaltrials |
| NCT04369703 | Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery | completed | — | 199 | Mayo ClinicOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT04076046 | Multicentric Prospective Validation of the Zurich Pituitary Score | completed | — | 408 | University of ZurichOTHER | 6 | Dec 17, 2021 | clinicaltrials |
| NCT04284605 | Effects Exercise Training in Patients With Pituitary Adenoma | completed | N/A | 10 | Hacettepe UniversityOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT02351700 | Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors | completed | Phase 4 | 62 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT04840771 | Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery | completed | — | 8 | Federico II UniversityOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT04546386 | Long-term Follow up for Retinal Vascular Changes After Endoscopic Endonasal Pituitary Surgery. | completed | — | 14 | Federico II UniversityOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT00001981 | The Treatment and Natural History of Acromegaly | completed | — | 117 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Nov 27, 2020 | clinicaltrials |
| NCT04425954 | Evaluation of Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery | completed | — | 14 | Federico II UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT00939523 | Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy | completed | Phase 2 | 9 | Cedars-Sinai Medical CenterOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02357498 | Transsphenoidal Extent of Resection Study(TRANSSPHER) | completed | N/A | 260 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT02727686 | Post-Operative Water Load Following Transsphenoidal Pituitary Surgery | completed | N/A | 30 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT01283542 | Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.(Passion I) | completed | Phase 2 | 20 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 26, 2019 | clinicaltrials |
| NCT01504399 | Rhinological Outcomes in Endonasal Pituitary Surgery | completed | — | 235 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT01459237 | Effects of Hormone Stimulation on Brain Scans for Cushing s Disease | completed | Early Phase 1 | 30 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Jun 14, 2018 | clinicaltrials |
| NCT02084134 | Peri-Operative Steroid Management in Patients(Steroid) | completed | N/A | 43 | Washington University School of MedicineOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT02574793 | Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects | completed | — | 60 | Huashan HospitalOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT03363126 | Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma(RetroADEN) | completed | — | 88 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 0 | Dec 6, 2017 | clinicaltrials |
| NCT03271918 | Cabergoline in Nonfunctioning Pituitary Adenomas | completed | Phase 3 | 140 | University of Sao Paulo General HospitalOTHER | 1 | Sep 7, 2017 | clinicaltrials |
| NCT01903967 | Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)(PITUIGENE) | completed | — | 213 | Hospices Civils de LyonOTHER | 1 | Jan 23, 2017 | clinicaltrials |
| NCT01371643 | Surgical Debulking of Pituitary Adenomas | completed | Phase 4 | 41 | NYU Langone HealthOTHER | 1 | Aug 29, 2016 | clinicaltrials |
Data updated 5 days agoSource updated Sep 22, 2026source: clinicaltrials